CERIMON PHARMACEUTICALS, INC.

Profile

Company Names

CERIMON PHARMACEUTICALS, INC.

Addresses

701 GATEWAY BLVD., #100, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650 827-4000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2004

State Incorporated:

DELAWARE

Total Amount Raised:

$2,965,917.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2010-11-01 
$232,957.00 
$250,000.00 
$17,043.00 
Equity 
3
2010-10-01 
$232,957.00 
$250,000.00 
$17,043.00 
Equity 
2
2010-03-30 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
1
2009-09-02 
$1,500,003.00 
$1,500,003.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ADELMAN 
DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SIENTRA, INC.   |  ARAGON PHARMACEUTICALS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  PRECISION BIOSCIENCES INC   |  METACRINE, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  TP THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.
ANSBERT 
 
GADICKE 
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.   |  CERIMON PHARMACEUTICALS, INC.   |  MPM BIOVENTURES V, L.P.   |  VERASTEM, INC.   |  ONCOLOGY INVESTORS OF TEXAS COSTIM, LLC   |  MITOKYNE, INC.   |  CLINICAL INK, INC.   |  VIRACYTE, INC.   |  ALLOVIR, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  ITEOS THERAPEUTICS, INC.   |  ONCOLOGY IMPACT FUND 2, L.P.   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  NEXTPOINT THERAPEUTICS, INC.   |  MPM BIOVENTURES 2022, L.P.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.
PAUL 
 
HASTINGS 
DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  RELYPSA INC   |  NKARTA, INC.   |  VIACYTE INC.
VAUGHN 
 
KAILIAN 
DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  VALERITAS INC   |  VASCULAR PHARMACEUTICALS, INC.
MATTHEW 
J. 
MEYER 
EXECUTIVE OFFICER
CERIMON PHARMACEUTICALS, INC.
GARY 
 
PATOU 
EXECUTIVE OFFICER
CERIMON PHARMACEUTICALS, INC.   |  KALIDEX PHARMACEUTICALS, INC.   |  BIOINTERVENE, INC.   |  BLADE THERAPEUTICS, INC.   |  STAR THERAPEUTICS LLC
DENISE 
 
POLLARD-KNIGHT 
DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  IDENIX PHARMACEUTICALS INC   |  ONCOMED PHARMACEUTICALS INC
JAMES 
 
SHANNON 
DIRECTOR
INDUS PACIFIC SMALLER COMPANIES FUND LTD   |  INDUS ASIA PACIFIC FUND, LTD.   |  INDUS EUROPE FUND, LTD.   |  INDUS EVENT DRIVEN FUND, LTD.   |  INDUS JAPAN FUND, LTD.   |  INDUS ALTERNATIVE EQUITY FUND, LTD.   |  XANODYNE PHARMACEUTICALS INC   |  INDUS PACIFIC OPPORTUNITIES FUND, LTD.   |  INDUS OMNI FUND, LTD.   |  CERIMON PHARMACEUTICALS, INC.   |  ARCH THERAPEUTICS, INC.   |  INDUS SELECT FUND, LTD.   |  INDUS OREAMNOS FUND, SPC - SEGREGATED PORTFOLIO 1   |  INDUS EMERGING MARKETS FUND, LTD.   |  INDUS CHINA FUND, LTD.   |  INDUS JAPAN LONG ONLY FUND, LTD.
JAMES 
S. 
SHANNON 
EXECUTIVE OFFICER, DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  ENDOCYTE INC
JAMES 
H. 
WELCH 
EXECUTIVE OFFICER
CERIMON PHARMACEUTICALS, INC.   |  ACELRX PHARMACEUTICALS INC   |  EIGER BIOPHARMACEUTICALS, INC.
SAMUEL 
P. 
WERTHEIMER 
DIRECTOR
NEURAXON(USA), INC.   |  CERIMON PHARMACEUTICALS, INC.   |  POLIWOGG HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-11-15
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-01 
2010-11-15
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-01 
2010-06-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-30 
2010-04-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-30 
2009-09-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#